Skip to content

Vysis 06N38-005

by Abbott Molecular

Vysis 06N38-005 is a medical device (FDA Class II) made by Abbott Molecular, listed in FDA GUDID since 20 Nov 2014 (UDI-DI 00884999025721), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00884999025721 UDI-DI Date20 Nov 2014ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ProbeChek ALK Negative Control Slides
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Vysis
Generic name
Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
Model / Ref / Catalog
06N38-005
Primary DI / UDI-DI
00884999025721
FDA product code
OYU, OWE
GMDN term
Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
Device class
Class II
Regulation number
866.4700, 864.1890
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code OYU (Dna-probe kit, human chromosome).

Other devices from Abbott Molecular

See all devices from Abbott Molecular →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)